FDA panel votes against BTG ’ s PneumRX Elevair
An FDA advisory committee panel yesterday voted against approving BTG‘s PneumRX’s Elevair endobronchial coil system intended for treating patients with severe emphysema. The panel voted 7 to 5 in favor of the device’s safety, but 8 to 3 that the benefits do not outweigh the risks, and 5 to 7 that the device was effective for use with patients in its proposed indications. The Elevair device is a nitinol endobronchial coil intended to be deployed bronchoscopically to reduce lung volume in patients with severe emphysema. The company submitted an application for premarket approval with the FDA, backed by clin...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Respiratory BTG Source Type: news

Self management of patients with mild COPD in primary care:
RCT (n=577 with mild dyspnoea) found telephone health coaching intervention delivered by nurses, underpinned by social cognitive theory led to changes in self-management activities but did not improve health related quality of life vs. usual care group (leaflet about COPD). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 15, 2018 Category: Consumer Health News Source Type: news

Pulmatrix touts Ph1 data for inhaled COPD therapy
Pulmatrix (NSDQ:PULM) touted data today from a dose-ranging Phase I trial of its once-daily inhaled therapy designed for people with chronic obstructive pulmonary disease. The company’s product is a reformulation of tiotropium bromide, the active component in Boehringer Ingelheim’s blockbuster drug, Spiriva. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix touts Ph1 data for inhaled COPD therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news

Aspergillus fumigatus During COPD Exacerbation Aspergillus fumigatus During COPD Exacerbation
A new study examines the clinical features and treatment outcomes of COPD patients with Aspergillus colonization.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Ex-smokers advised to use high nicotine e-cigarettes
Using low nicotine e-cigarettes devices more intensely may increase exposure to toxins in the vapour Related items fromOnMedica Fewer than ever women smoke at point of birth Million fewer smokers in France Public drastically underestimates cannabis risks E-cigs far safer than smoking, shows long-term research COPD patients need better tailored care (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 8, 2018 Category: UK Health Source Type: news

Digital health news briefs for 6/7/2018
Deep breaths.  Henry Schein Medical announced today the launch of its EasyOne Air Spirometer, a device designed to measure lung function and improve diagnosis of COPD. Connected via Bluetooth, the spirometer includes a touch screen interface, EHR connectivity, and proprietary technology to improve device calibra tion and accuracy. (Source: mobihealthnews)
Source: mobihealthnews - June 7, 2018 Category: Information Technology Source Type: news

Henry Schein Medical Launches Its New EasyOne Air Spirometer
New Portable Spirometry Solution Uses TrueFlow Ultrasound Technology for Precise and Reliable Diagnosis MELVILLE, N.Y., June 7, 2018 -- (Healthcare Sales & Marketing Network) -- Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nas... Devices, Product Launch Henry Schein, EasyOne Air, spirometer, Chronic Obstructive Pulmonary Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2018 Category: Pharmaceuticals Source Type: news

Mortality in Asthma-COPD Overlap in the United States Mortality in Asthma-COPD Overlap in the United States
Asthma-COPD overlap, or ACO, is recognized as a distinct clinical entity. What are the predominant causes of mortality among patients with ACO, and do they differ from those with asthma or COPD alone?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Umeclidinium cost effective for COPD in UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2018 Category: Drugs & Pharmacology Source Type: news

ResMed to acquire home and hospice software dev HealthcareFirst
ResMed (NYSE:RMD) said today it inked a deal to acquire healthcare software developer HealthcareFirst for an undisclosed amount. The soon-to-be acquired company develops software and services for both home health and hospice agencies, San Diego-based ResMed said. Offerings include electronic health record software, billing and coding services and advanced analytics for home and hospice settings. “Joining ResMed, with their purpose of changing lives with every breath, is an exciting opportunity for our HealthcareFirst team, as our joint mission is linked to improving quality of life for patients in out-of-ho...
Source: Mass Device - May 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Electronic Medical Records Mergers & Acquisitions Software / IT ResMed Inc. Source Type: news

It Turns Out Stapler Choice Matters in Lung Cancer Surgery
Video-assisted lobectomies performed with powered staplers resulted in nearly half as many patient bleeding complications as those conducted with manual staplers, according to a recent study. Patients treated with powered staplers were released from the hospital one day earlier than those whose surgeons used manual staplers. The retrospective study, funded by powered-stapler maker Ethicon, also indicated shortened hospital stays and 10% lower costs among the patients treated with the powered devices, most of which were manufactured by Ethicon, part of Johnson & Johnson. Most of the manual devices were made by Medtronic...
Source: MDDI - May 30, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: R & D Source Type: news

AstraZeneca drug Fasenra fails to achieve main goal in COPD trial
(Reuters) - AstraZeneca's first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD). (Source: Reuters: Health)
Source: Reuters: Health - May 30, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: Can vaping cause lung problems?
Many people turn to vaping as an alternative to smoking, but what are the effects of vapor on chronic obstructive pulmonary disease or COPD? Authorities are unsure about this new technology's effects on health. Learn here more about what the science says about the safety of vaping with COPD, and in general. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 29, 2018 Category: Consumer Health News Tags: COPD Source Type: news

COPD: No'Obesity Paradox' for BMI > 40
(MedPage Today) -- But the less severely obese survive better than normal-weight patients (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 25, 2018 Category: Endocrinology Source Type: news

Pulmonx Closing in On Approval for Valve to Treat Emphysema
Pulmonx has some additional ammunition in its bid to get its severe emphysema treatment valve FDA approval. The Redwood City, CA-based company released positive one-year-results from the LIBERATE pivotal trial of the Zephyr Endobronchial Valve, which shows the study met all primary and secondary endpoints in treating emphysema patients. Emphysema falls under the umbrella of chronic obstructive pulmonary disease (COPD) and is characterized by damage to the walls of the lungs between the air sacs, according to the National Emphysema Foundation. This damage causes the sacs to lose their shape and often, the destruction of tho...
Source: MDDI - May 25, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Source Type: news

Home Ventilation Saves $$$ Despite Initial Cost
(MedPage Today) -- COPD patients extend time away from doctors and hospital with add-on device (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 24, 2018 Category: Primary Care Source Type: news

Aspirin Appears Protective in COPD Patients
(MedPage Today) -- Too early for recommendations, but rate of'moderate acute'exacerbation was reduced (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 24, 2018 Category: Cardiology Source Type: news

Pulmonx touts quality of life, lung function improvements in 1-year Zephyr endobronchial valve IDE study
This study was the largest, longest study to use a less-invasive or minimally-invasive technique using these one-way valves,” Dr. Criner said. Dr. Criner said that after one year, patients treated with the Zephyr valves were significnatly more likely to show improvements in lung function, measured as forced expiratory volume in one second, or FEV1. “Patients that were treated had about a three times greater likelihood of having significant improvement in FEV1, more than 15% in 45% of the treated group compared to 11% of the control,” Dr. Criner said. Additionally, patients treated with the Zephyr reported...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory Pulmonx Source Type: news

LAMA Tx Didn't Up Heart Disease Riskin COPD
(MedPage Today) -- Cardiovascular outcomes similar to placebo-treated patients (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2018 Category: Allergy & Immunology Source Type: news

LAMA Tx Didn't Up Heart Disease Risk in COPD
(MedPage Today) -- Cardiovascular outcomes similar to placebo-treated patients (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 23, 2018 Category: Respiratory Medicine Source Type: news

Could Lawn Weed Prevent COPD Exacerbations?
(MedPage Today) -- Oral extract of speedwell plant deemed safe in phase IIa trial (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2018 Category: Allergy & Immunology Source Type: news

Warfarin Class Tied to Higher Death Rate in COPD
(MedPage Today) -- Retrospective results shouldn't change practice, but deserve more study (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 23, 2018 Category: Allergy & Immunology Source Type: news

Spiolto ® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease
Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical activity in patients living with COPD. VESUTO® and OTIVATO® data were presented during the American Thoracic Society meeting (ATS) and PHYSACTO® data was recently published in the American Journal of Respiratory and Critical Care Medicine. (Source: World Pharma News)
Source: World Pharma News - May 23, 2018 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

Chronic Obstructive Pulmonary Disease (COPD)
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 23, 2018 Category: General Medicine Source Type: news

IFNL3/4 and IFNL3 Associated With COPD Severity and Outcomes IFNL3/4 and IFNL3 Associated With COPD Severity and Outcomes
In what ways might interferon lambdas impact exacerbations and outcomes in COPD?BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 23, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

COPD: Combo Tx Promising for Rapid Bronchodilation
(MedPage Today) -- Greater than 100 ml increase in peak FEV1 with RPL554 plus Spiriva (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 22, 2018 Category: Primary Care Source Type: news

Step-Down Therapy in Severe COPD OK for Some
(MedPage Today) -- But patients with high eosinophilic burden need triple therapy (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 22, 2018 Category: Allergy & Immunology Source Type: news

Medical News Today: What to know about centrilobular emphysema
Centrilobular emphysema is a form of emphysema where the damage begins in the central lobes of the lungs and spreads outward. This is distinct from panlobular emphysema. In this article, we discuss centrilobular emphysema including symptoms, causes, complications, and possible treatments. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 22, 2018 Category: Consumer Health News Tags: COPD Source Type: news

ResMed touts cost efficiency in home oxygen, non-invasive ventilation therapy study
ResMed (NYSE:RMD) today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of chronic obstructive pulmonary disorder, touting an increase in cost efficiency with the combined therapy. Results from the two studies, performed in the U.K. and the US, were presented at the ATS 2018 International Conference this week, the San Diego-based company said. Data from the U.K.-based study reported that the combined home treatments reduced exacerbation frequency and 28-day hospital re...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory ResMed Inc. Source Type: news

Innovative risk score tool effectively predicts future risk of hospitalization for COPD patients
(Intermountain Medical Center) Researchers have developed a new tool that utilizes basic laboratory tests to effectively identify patients with chronic obstructive pulmonary disease who are at high risk of being hospitalized due to a flare up of the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 21, 2018 Category: International Medicine & Public Health Source Type: news

Inhaled Corticosteroids in COPD Raises Fracture Risk
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - May 16, 2018 Category: Orthopaedics Tags: CME Article Source Type: news

How an injection to thin blood can also help you breathe more easily  
Heparin, a drug that has been around for more than 100 years, significantly improves lung function and breathing in patients with chronic obstructive pulmonary disease. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2018 Category: Consumer Health News Source Type: news

How an injection to thin the blood can also help you breathe more easily  
Heparin, a drug that has been around for more than 100 years, significantly improves lung function and breathing in patients with chronic obstructive pulmonary disease. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2018 Category: Consumer Health News Source Type: news

AstraZeneca's Drug Fasenra Flops in COPD Trial AstraZeneca's Drug Fasenra Flops in COPD Trial
AstraZeneca's said its first respiratory biologic medicine Fasenra (benralizumab) failed to meet its target in a clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 14, 2018 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

U.K. group uses math to characterize lung disease on CT
Researchers from the U.K. have developed a method that uses a combination of...Read more on AuntMinnie.comRelated Reading: Genetic variation in lung airways elevates risk of COPD AI algorithm predicts lung disease, adverse events on CT Advanced visualization tool assesses lung disease COPD severity mirrors lung cancer incidence AJR: Ultralow-dose CT can evaluate COPD (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2018 Category: Radiology Source Type: news

Fall episodes in elderly patients with asthma and COPD - a pilot study - Bozek A, Jarzab J, Hadas E, Jakalski M, Canonica GW.
OBJECTIVE: Evidence of an increased risk of falls in patients with chronic obstructive pulmonary disease (COPD) exists; however, this has not been studied in elderly asthmatic patients. The aim of the study was to determine the incidence of falls in elderl... (Source: SafetyLit)
Source: SafetyLit - May 11, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

AstraZeneca provides update on GALATHEA Phase III trial for Fasenra in chronic obstructive pulmonary disease
AstraZeneca and MedImmune, its global biologics research and development arm, today announced top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). The trial did not meet the primary endpoint of a statistically-significant reduction of exacerbations in patients with COPD. (Source: World Pharma News)
Source: World Pharma News - May 11, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

AstraZeneca's drug Fasenra flops in COPD trial
LONDON (Reuters) - AstraZeneca's said its first respiratory biologic medicine Fasenra failed to meet its target in a clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD). (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Lays the Smackdown on Illegal Stem Cell Clinics
FDA is cracking down on stem cell clinics that market unapproved products and don't meet good manufacturing practice requirements. On behalf of the agency, the Department of Justice filed two complaints in federal court this week seeking permanent injunctions against a Florida-based clinic and a California-based clinic.  “Cell-based regenerative medicine holds significant medical opportunity, but we’ve also seen some bad actors leverage the scientific promise of this field to peddle unapproved treatments that put patients’ health at risk. In some instances, patients have suffered serious and per...
Source: MDDI - May 10, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

' Frequent Exacerbator' Phenotype in COPD Is Real
(MedPage Today) -- Two or more annual exacerbations predicts poor prognosis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 10, 2018 Category: Primary Care Source Type: news

How the power of mathematics can help assess lung function
(University of Southampton) Researchers at the University of Southampton have developed a new computational way of analyzing X-ray images of lungs, which could herald a breakthrough in the diagnosis and assessment of chronic obstructive pulmonary disease (COPD) and other lung diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2018 Category: International Medicine & Public Health Source Type: news

Occupational exposures linked with increased risk of COPD
(Barcelona Institute for Global Health (ISGlobal)) A study with more than 3,300 participants in 12 countries has established a relationship between occupational exposure to biological dusts, gases, fumes and pesticides and COPD. The researchers did a follow-up of the participants 20 years after the first assessment. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 9, 2018 Category: Biology Source Type: news

Smoking and Death; Vessels for CABG: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include the best blood vessel for cardiac bypass grafts, rates of autism, five healthy lifestyle factors and their impact on mortality, and managing COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 5, 2018 Category: Respiratory Medicine Source Type: news

Fixed-Dose LABA-LAMA COPD Treatment Little Better Than LAMA Alone
(MedPage Today) -- But concomitant use of inhaled steroids complicates interpretation (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 4, 2018 Category: Primary Care Source Type: news

Supplemental Oxygen Has Limited Powers Supplemental Oxygen Has Limited Powers
Should you reconsider writing oxygen prescriptions? Dr Holley discusses a new review on home oxygen therapy for COPD.Medscape Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 2, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Viewpoint Source Type: news

Hospital-in-the-Home Shows Promise for Reducing Acute Care Costs; Medical Laboratories Face Uncertainties Concerning Expanding Services to In-Home Environments in Support of Care Providers
Despite logistics and test volume concerns for laboratories, hospital-in-the-home services promise to reduce cost and improve quality of care for patients who might be negatively impacted by the noise, stress, and germs of busy hospitals In April, The Washington Post highlighted the plight of 71-year-old Phyllis Petruzzelli—a patient with a weakened immune system suffering from […] (Source: Dark Daily)
Source: Dark Daily - May 2, 2018 Category: Laboratory Medicine Authors: Jude Tags: Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Testing anatomic pathology asthma Brigham and Women’s Faulkner Hospital Chronic Obstructive Pulmonary Disease clinical laboratory David Levine MD De Source Type: news

Health Tip: Recognizing Lung Disease
-- You shouldn't ignore a nagging cough or mild wheeze. They could be symptoms of a lung disease, such as asthma, COPD or cancer, the American Lung Association says. Here are the association's potential warning signs of lung disease: Cough... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 2, 2018 Category: General Medicine Source Type: news

A breath of FRESH AIR for tackling lung diseases
Chronic obstructive pulmonary disease (COPD) is now the third leading cause of death worldwide, particularly in low-income settings. EU-funded researchers are working to improve outcomes for populations across the world by ensuring the implementation of best practice based on scientific evidence. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - April 30, 2018 Category: Research Source Type: news

Medical News Today: Do BiPAP machines work for COPD?
A BiPAP machine is a small breathing device that can help a person with COPD to breathe more easily. It can be used at night or when symptoms flare. BiPAP therapy stabilizes air pressure, helping the lungs to inflate and deflate. BiPAP is not necessary for everyone but can improve life quality for some with COPD. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 27, 2018 Category: Consumer Health News Tags: COPD Source Type: news

Theravance Biopharma touts expanded FDA nod for GSK ’ s Trelegy Ellipta inhaler
Theravance Biopharma‘s (NSDQ:TBPH) said today that the FDA granted expanded indications for GlaxoSmithKline‘s (NYSE:GSK) Trelegy Ellipta inhaler, now approved for use to treat a broader population of chronic obstructive pulmonary disease patients. With the expansion, the inhaler is now cleared for COPD patients with airflow limitations and for those who have experienced an acute worsening of respiratory symptoms, the Dublin-based company said. The system is intended as a long-term, once-daily maintenance to treat airflow obstructions, as well as to reduce exacerbations of COPD. Read the whole story on our ...
Source: Mass Device - April 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Drug-Device Combinations Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Theravance Source Type: news